BMO Capital Downgrades Verve Therapeutics (VERV) to Market Perform
Go back to BMO Capital Downgrades Verve Therapeutics (VERV) to Market Perform| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1166.98 -9.12 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1176.10 | 52 Week High | $88.16 | |||
| Open | $1172.66 | 52 Week Low | $67.88 | |||
| Day High | $1174.00 | P/E | 270.13 | |||
| Day Low | $1163.90 | EPS | $4.32 | |||
| Volume | 180,448 | |||||
| (NASDAQ: VERV) | Delayed: 11.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.13 | 52 Week High | $ | |||
| Open | $11.13 | 52 Week Low | $ | |||
| Day High | $11.13 | P/E | N/A | |||
| Day Low | $11.13 | EPS | $ | |||
| Volume | 20,718 | |||||

